Myeloproliferative Neoplasm (MPN) Specialists

Hear directly from oncologists who specialize in MPNs.

Lymphoma is a cancer that starts in the bone marrow, where blood cells are made. There are three main types: Polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF).

Explore interviews with medical experts who specialize in MPNs, including oncologists who talk about latest in treatment trends and options. Explore below also to hear from other medical team members like nurses and social workers who share more on navigating the day-to-day life with cancer.

MPN Oncologists


Srdan Verstovsek, MD, PhD



Role: Director, Clinical Research Center for MPNs at MD Anderson; Section Chief, MPNs; Prof., Dept. of Leukemia
Focus: Myeloproliferative neoplasms (MPN)
Institution: MD Anderson
Dr. Serge Verstovsek and Dr. Naveen Pemmaraju

Myelofibrosis Highlights from ASH 2022



Dr. Serge Verstovsek and Dr. Naveen Pemmaraju discuss cutting-edge treatments and therapies, and combination therapy as a focus in treating myelofibrosis.

The Latest in Myelofibrosis Treatments - Clinical Trials

Clinical Trials and You: How to Navigate Treatment?



Patient advocate Ruth Fein Revell, experts Dr. Angela Fleischman and Dr. Ruben Mesa, together with clinical trial nurse Melissa Melendez delve into the cutting-edge realm of myelofibrosis clinical trials.

Ruben Mesa, MD



Role: Executive Director, Mays Cancer Center; Prof. of Medicine
Focus: Myeloproliferative neoplasms (MPN)
Institution: UT Health San Antonio MD Anderson